<p>Cladophora cellulose polypyrrole composites are recognized as potential biomaterials with future applications in hemodialysis. In this project conductive Cladophora cellulose-polypyrrole (clad-ppy) composites were prepared using two different oxidizing agents: iron (III) chloride and phosphomolybdic acid (PMo). Cyclic voltammetry, conductivity and Specific surface area measurements were done to characterize the synthesized composites. Furthermore in vitro blood compatibility studies were performed. Whole blood was incubated with clad-ppy membranes and then blood was analyzed for platelet number reduction and complement activation products (C3a and sC5b-9). Clad-ppy with Iron (III) chloride membranes were found to be superior in terms of conductivity and surface area while Clad-ppy with PMo membranes were found to provoke less blood activation. The results indicated that each oxidizing agent gave distinct properties to the composite material.</p>

Cladophora cellulose polypyrrole composites are recognized as potential biomaterials with future applications in hemodialysis. In this project conductive Cladophora cellulose-polypyrrole (clad-ppy) composites were prepared using two different oxidizing agents: iron (III) chloride and phosphomolybdic acid (PMo). Cyclic voltammetry, conductivity and Specific surface area measurements were done to characterize the synthesized composites. Furthermore in vitro blood compatibility studies were performed. Whole blood was incubated with clad-ppy membranes and then blood was analyzed for platelet number reduction and complement activation products (C3a and sC5b-9). Clad-ppy with Iron (III) chloride membranes were found to be superior in terms of conductivity and surface area while Clad-ppy with PMo membranes were found to provoke less blood activation. The results indicated that each oxidizing agent gave distinct properties to the composite material.

Yes / Highly-oriented poly(l-lactic acid) (PLLA) with fibrillar structure and micro-grooves was fabricated through solid hot drawing technology for further improving the mechanical properties and blood biocompatibility of PLLA as blood-contacting medical devices. In order to enhance the melt strength and thus obtain high orientation degree, PLLA was first chain extended with ethylene glycol diglycidyl ether (EGDE). The extending degree as high as 25.79 mol% can be obtained at 0.7 wt% EGDE content. The complex viscosity, storage and viscous modulus for chain extended PLLA were improved resulting from the enhancement of molecular entanglement, and consequently higher draw ratio can be achieved during the subsequent hot stretching. The tensile strength and modulus of PLLA were improved dramatically by stretching. The stress-induced crystallization of PLLA occurred during drawing. The interfacial tension (γs·blood) between PLLA surface and blood decreased by chain extension and molecular orientation, indicating the weakened interaction between bioactive substance in the blood and the surface of PLLA. Modification and orientation could significantly enhance the blood compatibility of PLLA by prolonging clotting time and decreasing hemolysis ratio, protein adsorption and platelet activation. The bionic character of oriented PLLA and its anti-coagulation mechanism were tried to be explored. / This research was supported by National Natural Science Foundation of China (Grant No. 51303109)

With growing demand for cardiovascular implants, improving the performance of artificial blood-contacting devices is a task that deserves close attention. Current prostheses made of fluorocarbon polymers such as expanded polytetrafluoroethylene (ePTFE) suffer from early thrombosis and require periodic replacement. A great number of attempts have already been made to improve blood compatibility of artificial surfaces, but only few of them found commercial implementation. One of the surfaces under intensive research for cardiovascular use is amorphous carbon-based coatings produced by means of the plasma-assisted deposition. However, this class of coatings can be produced using various techniques leading to a number of coatings with different properties. Carbon coatings produced in different plasmas may be of hard diamond-like type or soft graphite-like type, doping with different elements also changes the surface structure and properties. Taking this into account, the search for blood-compatible coating requires the understanding of surface composition and structure and its influence on blood-compatibility. This work attempts to advance our knowledge of this field. Here, commercial PTFE thin film was used as a working material, which composition corresponds to the composition of modern ePTFE vascular grafts and which compatibility with blood we tried to improve by deposition of nitrogenated amorphous carbon (a-CN) coatings in the plasma. Biocompatibility was assessed by a number of tests including the interaction with whole blood and various cells such as platelets, endothelial cells, neutrophils, and fibroblasts. Most of tests showed the blood compatibility of coated surface is better than that of untreated PTFE. Physico-chemical and morphological properties of coated surfaces were studied in parallel using x-ray photoemission spectroscopy (XPS), electron energy loss spectroscopy (EELS), x-ray absorption spectroscopy (XAS), Raman spectroscopy, Fourier transform infrared spectroscopy (FTIR), atomic force microscopy (AFM). Some correlation between the structure of coatings and blood compatibility was inferred. It was found that at first nitrogen incorporation into amorphous carbon film stimulates blood compatibility. However, when nitrogen fraction increases over 23-25 %, no further improvement but reduction of blood compatibility was observed. Conclusion is made that for best biomedical performance, nitrogen percentage in a-CN coatings must be adjusted to the optimum value.

With growing demand for cardiovascular implants, improving the performance of artificial blood-contacting devices is a task that deserves close attention. Current prostheses made of fluorocarbon polymers such as expanded polytetrafluoroethylene (ePTFE) suffer from early thrombosis and require periodic replacement. A great number of attempts have already been made to improve blood compatibility of artificial surfaces, but only few of them found commercial implementation. One of the surfaces under intensive research for cardiovascular use is amorphous carbon-based coatings produced by means of the plasma-assisted deposition. However, this class of coatings can be produced using various techniques leading to a number of coatings with different properties. Carbon coatings produced in different plasmas may be of hard diamond-like type or soft graphite-like type, doping with different elements also changes the surface structure and properties. Taking this into account, the search for blood-compatible coating requires the understanding of surface composition and structure and its influence on blood-compatibility. This work attempts to advance our knowledge of this field. Here, commercial PTFE thin film was used as a working material, which composition corresponds to the composition of modern ePTFE vascular grafts and which compatibility with blood we tried to improve by deposition of nitrogenated amorphous carbon (a-CN) coatings in the plasma. Biocompatibility was assessed by a number of tests including the interaction with whole blood and various cells such as platelets, endothelial cells, neutrophils, and fibroblasts. Most of tests showed the blood compatibility of coated surface is better than that of untreated PTFE. Physico-chemical and morphological properties of coated surfaces were studied in parallel using x-ray photoemission spectroscopy (XPS), electron energy loss spectroscopy (EELS), x-ray absorption spectroscopy (XAS), Raman spectroscopy, Fourier transform infrared spectroscopy (FTIR), atomic force microscopy (AFM). Some correlation between the structure of coatings and blood compatibility was inferred. It was found that at first nitrogen incorporation into amorphous carbon film stimulates blood compatibility. However, when nitrogen fraction increases over 23-25 %, no further improvement but reduction of blood compatibility was observed. Conclusion is made that for best biomedical performance, nitrogen percentage in a-CN coatings must be adjusted to the optimum value.

Polymeric surfaces were modified and the impact on the blood compatible properties investigated.

The heart is one of the most important organs of the human body and cardiovascular diseases remain the biggest cause of deaths worldwide. Today, due to the aging of the population and the growing demand for cardiovascular implants, improving the performance of artificial surfaces of vascular prostheses is highly desired. The common material for fabricating prostheses, such as stents used to remedy narrow and weak arteries, is Fluorocarbon polymers or expanded Polytetrafluoroethylene (ePTFE, Gore-tex). Although these polymers are well known for chemical inertness, thermal stability and low friction, they can cause early thrombosis (forming clot) and coagulation in blood vessels and require periodic replacement. Modifying the surface properties of Polytetrafluoroethylene (PTFE) by coating with carbon-based materials may improve its blood compatibility. Carbon-based coatings have properties similar to biomedical components, such as low friction, bioinertness, high wear resistance and exceptional hardness. Plasma processing methods are commonly used for coating thin films on various materials including carbon-based components. Plasma-based processes are also widely used in the aerospace, automotive, steel and biomedical industries. For example, extending the lifetime of surgically implanted hip joints and cutting tools are biomedical and industrial applications of plasma-based material processing respectively. Plasma-assisted deposition techniques are commonly used for carbon-based coating including nitrogen-doped amorphous carbon (a-C) films. In this thesis, PTFE samples with different thickness and roughness characteristics are used as substrates and diamond-like carbon (DLC) is deposited on them by simultaneous plasma-assisted sputtering and chemical vapour deposition (CVD). Hot filament plasma and ICP (Inductively coupling plasma) are used to coat DLC on PTFE and silicon (Si) substrates under various plasma conditions. The latter is the first report on the techniques to coat DLC by ICP plasma sputtering. This new technique (ICP-sputtering) is developed to improve low deposition rate and high temperature deposition of previous method (Hot filament plasma sputtering). Advantageous of this new developed method (ICP-sputtering) are discussed and compared with the previous method in this thesis. Various amount of nitrogen is introduced to the plasma chambers and the effect of nitrogen dopant is also studied using different characterization techniques for chemical, electronic and morphological properties of coated films. sp2 and sp3 contents were also estimated in amorphous carbon (a-C) and nitrogenated amorphous carbon (a-CN) films. Characterization techniques used for in this thesis are including SEM (scanning electron microscopy), AFM (atomic force microscopy), Raman spectroscopy, XAS (x-ray absorption spectroscopy), XES (x-ray emission spectroscopy), XPS (x-ray photoelectron spectroscopy) and XRD (x-ray diffraction).

Nanocellulose has received considerable interest during the last decade because it is renewable and biodegradable, and has excellent mechanical properties, nanoscale dimensions and wide functionalization possibilities. It is considered to be a unique and versatile platform on which new functional materials can be based. This thesis focuses on nanocellulose from wood (NFC) and from Cladophora algae (CNC), functionalized with surface charges or coated with the conducting polymer polypyrrole (PPy), aiming to study the influence of synthesis processes on structural and electrochemical properties of such materials and assess their biocompatibility. The most important results of the work demonstrated that 1) CNC was oxidized to the same extent using electrochemical TEMPO-mediated oxidation as with conventional TEMPO processes, which may facilitate easier reuse of the reaction medium; 2) NFC and CNC films with or without surface charges were non-cytotoxic as assessed by indirect in vitro testing. Anionic TEMPO-CNC films promoted fibroblast adhesion and proliferation in direct in vitro cytocompatibility testing, possibly due to its aligned fibril structure; 3) Rinsing of PPy-coated nanocellulose fibrils, which after drying into free-standing porous composites are applicable for energy storage and electrochemically controlled ion extraction, significantly degraded the PPy coating, unless acidic rinsing was employed. Only minor degradation was observed during long-term ambient storage; 4) Variations in the drying method as well as type and amount of nanocellulose offered ways of tailoring the porosities of nanocellulose/PPy composites between 30% and 98%, with increments of ~10%. Supercritical CO2-drying generated composites with the largest specific surface area yet reported for nanocellulose/conducting polymer composites (246 m2/g). The electrochemical oxidation rate was found to be controlled by the composite porosity; 5) In blood compatibility assessments for potential hemodialysis applications, heparinization of CNC/PPy composites was required to obtain thrombogenic properties comparable to commercial hemodialysis membranes. The pro-inflammatory characteristics of non-heparinized and heparinized composites were, to some extent, superior to commercial membranes. The heparin coating did not affect the solute extraction capacity of the composite. The presented results are deemed to be useful for tuning the properties of systems based on the studied materials in e.g. energy storage, ion exchange and biomaterial applications.

All artificial organ systems and medical devices that operate in direct contact with blood elicit activation of coagulation and platelets, and their long-term use often necessitates antithrombotic therapies that carry significant cost and bleeding risk. Thrombomodulin (TM) is a major endogenous inhibitor of blood coagulation localized on the endothelial cell surface. The overall objective of this research is to develop clinically durable synthetic materials by incorporating TM as a solid-supported film to actively and sustainably attenuate thrombus formation at the blood-contacting interface. During the course of this research, we developed site-specific approaches to covalently attach TM on the luminal surface of commercial vascular grafts using bioorthogonal chemistry that was compatible with ethylene oxide sterilization. Notably, we demonstrated the superior efficacy of TM to reduce platelet deposition compared with commercial heparin modified grafts using a non-human primate model of acute graft thrombosis. Finally, we optimized a novel reversible chemistry to rapidly and repeatedly regenerate immobilized TM, with the potential to significantly extend the lifetime of biologically active films.

Polymeric surfaces were modified and the impact on the blood compatible properties investigated.